METROPOLIS HEALTHCARE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,778 INR | -3.47% |
|
+1.87% | +5.93% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
Calendar
2024-05-13
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
1,778
INR
Average target price
1,682
INR
Spread / Average Target
-5.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.93% | 1.09B | |
| -17.49% | 8.3B | |
| +37.68% | 3.52B | |
| -25.86% | 3B | |
| -6.65% | 2.53B | |
| -9.71% | 2.31B | |
| -14.65% | 1.76B | |
| -22.17% | 1.51B | |
| -37.04% | 1.29B | |
| -5.83% | 1.1B |
- Stock Market
- Equities
- METROPOLIS Stock
- News Metropolis Healthcare Limited
- Metropolis Healthcare : Consolidated Profit Soars in Fiscal Q1
